Dr Reddys Laboratories Share Price Today - Live Blog for September 02, 2025

The stock of Dr Reddys Laboratories Ltd suffered a -0.36% decline, and it currently trades at ₹1,250.50 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Dr Reddys Laboratories Ltd's share price has fallen by -0.27%, a situation worth noting. At present, the stock is trading at ₹1,253.50. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 18.8100, while the industry PE ratio is 34.3368.

Dr Reddys Laboratories Ltd stock price decreased by -0.15%, with the current market value at ₹1,257.35 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.04%, reaching a current market price of ₹1,262.65. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

After a -0.04% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,262.65. The stock has a PE ratio of 18.8100, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The share price of Dr Reddys Laboratories Ltd recently experienced a positive upturn, resulting in a 0.16% increase. Presently, it is actively trading at ₹1,264.55.

With a -0.24% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,262.50. Investors should examine the factors driving this decline. The stock's PE ratio is 18.8100, whereas the industry PE ratio stands at 34.3368.

The stock of Dr Reddys Laboratories Ltd suffered a -0.18% drop, and it's now trading at ₹1,266.80 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.33%, signalling a challenging period. Currently trading at ₹1,266.30, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Dr Reddys Laboratories Ltd shares experienced a -0.33% reduction, with the current market price at ₹1,266.30. Investors are carefully considering their positions and seeking insights into the stock's future performance.

Dr Reddys Laboratories Ltd's stock has surged by 0.35%, and it is currently trading at ₹1,270.55. Additionally, the stock maintains a PE ratio of 18.8100, while the industry PE is 34.3368.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.35% gain, with the share price now at ₹1,270.55. Notably, the stock's PE ratio stands at 18.8100, and its Return on Equity (ROE) is 16.8559%.

After a -0.04% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,267.10. The stock has a PE ratio of 18.8100, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd experienced a -0.04% downturn in its share price, and it's currently trading at ₹1,267.10. This situation is generating interest among value investors who are evaluating the stock's potential.

The stock of Dr Reddys Laboratories Ltd suffered a -0.04% drop, and it's now trading at ₹1,267.10 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 0.01% increase and currently trading at ₹1,268.25 per share. Investors are taking notice of this upward momentum.

Dr Reddys Laboratories Ltd stock price decreased by -0.17%, with the current market value at ₹1,268.10 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

With a -0.00% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,271.45. The stock is currently trading at a PE of 18.8100, while the industry PE is 34.3368, prompting investors to assess its value proposition.

Dr Reddys Laboratories Ltd's stock has surged by 0.00%, and it is currently trading at ₹1,271.05. Additionally, the stock maintains a PE ratio of 18.8100, while the industry PE is 34.3368.

The stock of Dr Reddys Laboratories Ltd is facing a -0.13% decline and is currently trading at ₹1,271.35 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Dr Reddys Laboratories Ltd experienced a -0.07% downturn in its share price, and it's currently trading at ₹1,270.50. This situation is generating interest among value investors who are evaluating the stock's potential.

The share price of Dr Reddys Laboratories Ltd recently experienced a positive upturn, resulting in a 0.06% increase. Presently, it is actively trading at ₹1,270.50.

After a notable 0.06% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,270.50. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

Dr Reddys Laboratories Ltd experienced a -0.03% dip in its share price and is currently trading at ₹1,269.00. The stock has a PE ratio of 18.8100, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.33%, reaching the current market price of ₹1,271.05. This development underscores the stock's growing popularity.

Dr Reddys Laboratories Ltd witnessed a -0.24% drop in its share price and is currently trading at ₹1,265.45. With the stock's PE at 18.8100 and the industry PE at 34.3368, investors are weighing their options.

Dr Reddys Laboratories Ltd experienced a -1.02% downturn in its share price, and it's currently trading at ₹1,266.90. This situation is generating interest among value investors who are evaluating the stock's potential.